Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol in African American Hypertension
NCT00145210Phase 3Completed
- Sponsor
- Viatris
- Start
- Apr 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nebivolol in hypertension (HTN) (3 arms), sponsored by Viatris. Primary endpoints: Sitting Diastolic Blood Pressure at 12 weeks and Heart Rate at 12 weeks. Started Apr 2005; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00145210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145210.